Autonomic Testing as a Standard of Care: A Clinical Imperative

Elevating Diagnostic Accuracy in Neurology

For neurologists managing patients with complex presentations, the autonomic nervous system (ANS) often acts as a bridge between seemingly disparate symptoms. Despite the prevalence of dysautonomia in conditions ranging from small-fiber neuropathy to metabolic disorders, the diagnostic pathway has historically been fragmented. However, as clinical evidence matures, autonomic testing standards are increasingly being recognized as a standard of care essential for comprehensive patient management.

Clinical Guidelines and the Mandate for ANS Assessment

Modern autonomic nervous system guidelines emphasize that early detection of autonomic dysfunction is critical for mitigating morbidity in patients with systemic diseases. The American Diabetes Association (ADA) consistently identifies cardiovascular autonomic neuropathy (CAN) as a major complication of diabetes, recommending standardized screening to prevent sudden cardiac death and silent myocardial ischemia. Similarly, the American Heart Association (AHA) and American College of Cardiology (ACC) support integrated assessment strategies for patients demonstrating unexplained syncope, orthostatic intolerance, or progressive neurodegenerative symptoms.

By adhering to these clinical guidelines autonomic testing allows for the objective quantification of parasympathetic and sympathetic integrity. Rather than relying on subjective patient reporting, clinicians can utilize physiologic data to guide therapeutic interventions and track disease progression.

Integrating Advanced Diagnostics: The VitalScan ANS+

Implementing rigorous diagnostic protocols often presents logistical challenges in a busy neurology practice. The VitalScan ANS+ system, developed by US MedResources, is engineered to bridge this gap. This FDA-cleared, non-invasive platform provides a comprehensive suite of tests—including Heart Rate Variability (HRV), Valsalva ratio, orthostatic blood pressure response, and sudomotor function (SudoCheck)—within a 15-minute timeframe.

Because the system is designed to be administered by existing clinical staff, it eliminates the need for specialized technicians or off-site referrals. The resulting automated interpretive report provides immediate actionable data, allowing physicians to discuss findings with the patient during the same encounter. Furthermore, the inclusion of Pulse Wave Velocity (PWV) and Ankle-Brachial Index (ABI) modules ensures that vascular health is evaluated alongside autonomic function, providing a holistic view of the patient's cardiovascular profile.

Clinical Implementation and Revenue Workflow

Autonomic function testing is not only a clinical necessity but a sustainable addition to a practice’s economic model. By utilizing established CPT billing codes, practices can reliably capture the value of these services:

• Autonomic Nervous System Testing: CPT 95921-95924
• Vascular Studies: CPT 93922-93971

Given the 30-year track record of US MedResources in the diagnostics space, the VitalScan ANS+ is built to ensure high-fidelity data that supports medical necessity documentation for these codes. For neurologists, this provides a clear pathway to justify high-quality diagnostic oversight while improving clinic efficiency.

Precision Care for Complex Presentations

In clinical practice, we often encounter patients with vague symptoms like dizziness, chronic fatigue, or distal paresthesia that defy standard neurological workups. Autonomic testing provides the objective evidence required to differentiate between primary and secondary dysautonomia. Whether you are managing Parkinson’s disease, diabetic peripheral neuropathy, or idiopathic orthostatic hypotension, the VitalScan ANS+ provides the granular data points needed to tailor pharmacological and lifestyle interventions effectively.

Key Takeaway

Aligning with current autonomic testing standards is no longer an optional endeavor; it is a clinical standard of care that significantly enhances diagnostic precision for patients with neurological and systemic comorbidities. Integrating platforms like the VitalScan ANS+ allows for rapid, accurate, and reimbursable autonomic assessment, enabling physicians to move from symptom management to evidence-based, physiologic-driven clinical decision-making.